Literature DB >> 8167518

Disagreements are not substantial.

M R Law1, N J Wald.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8167518      PMCID： PMC2539874          DOI： 10.1136/bmj.308.6935.1027

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Apolipoproteins and ischaemic heart disease: implications for screening.

Authors:  N J Wald; M Law; H C Watt; T Wu; A Bailey; A M Johnson; W Y Craig; T B Ledue; J E Haddow
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

2.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05

3.  Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.

Authors:  M R Law; N J Wald; T Wu; A Hackshaw; A Bailey
Journal:  BMJ       Date:  1994-02-05

4.  Assessing possible hazards of reducing serum cholesterol.

Authors:  M R Law; S G Thompson; N J Wald
Journal:  BMJ       Date:  1994-02-05

5.  Cholesterol lowering and mortality: the importance of considering initial level of risk.

Authors:  G D Smith; F Song; T A Sheldon
Journal:  BMJ       Date:  1993-05-22

6.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321
  6 in total
  2 in total

Review 1.  The importance of diet and physical activity in the treatment of conditions managed in general practice.

Authors:  P Little; B Margetts
Journal:  Br J Gen Pract       Date:  1996-03       Impact factor: 5.386

2.  Statins for primary prevention: at what coronary risk is safety assured?

Authors:  P R Jackson; E J Wallis; I U Haq; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.